Literature DB >> 29759308

The Value of Adjuvant Radiotherapy in Cutaneous Squamous Cell Carcinoma: A Review.

J Cañueto1, A Jaka2, A Toll3.   

Abstract

Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer in humans and its incidence is rising. Although surgery is the treatment of choice for cSCC, postoperative adjuvant radiotherapy has an important role in local and locorregional disease control. In this review, we analyze the value of postoperative radiotherapy in the management of high-risk cSCC (in particular, cases with perineural invasion), cSCC with positive surgical margins, and locally advanced cSCC (with parotid gland and/or lymph node metastasis).
Copyright © 2018 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Adjuvant; Adyuvancia; Alto riesgo; Carcinoma escamoso cutáneo; Cutaneous squamous cell carcinoma; High-risk; Postoperative; Postoperatorio; Radioterapia; Radiotherapy

Mesh:

Year:  2018        PMID: 29759308     DOI: 10.1016/j.ad.2018.03.007

Source DB:  PubMed          Journal:  Actas Dermosifiliogr (Engl Ed)        ISSN: 2173-5778


  4 in total

Review 1.  Radiotherapy in the Adjuvant and Advanced Setting of CSCC.

Authors:  Paolo Muto; Francesco Pastore
Journal:  Dermatol Pract Concept       Date:  2021-10-01

Review 2.  Treatment of keratinocyte carcinoma in elderly patients - a review of the current literature.

Authors:  A J G Leus; M Frie; M S Haisma; J B Terra; B E C Plaat; R J H M Steenbakkers; G B Halmos; E Rácz
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-03-30       Impact factor: 6.166

Review 3.  Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.

Authors:  Luca Fania; Dario Didona; Francesca Romana Di Pietro; Sofia Verkhovskaia; Roberto Morese; Giovanni Paolino; Michele Donati; Francesca Ricci; Valeria Coco; Francesco Ricci; Eleonora Candi; Damiano Abeni; Elena Dellambra
Journal:  Biomedicines       Date:  2021-02-09

4.  MicroRNA-573 inhibits cell proliferation, migration and invasion and is downregulated by PICSAR in cutaneous squamous cell carcinoma.

Authors:  Yanhua Wang; Shengjian Tang; Jianping Lv
Journal:  Bosn J Basic Med Sci       Date:  2022-04-01       Impact factor: 3.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.